TMCnet News
Global Cervical Cancer Diagnostics & Therapeutic Market - Increase of Pipeline Cervical Cancer Screening Tests - Research and MarketsResearch and Markets has announced the addition of the "Global Cervical Cancer Diagnostics and Therapeutic Market - Segmented by diagnostic test, method, end user, therapy and geography (2014-2020)" report to their offering. The global cervical cancer market was valued at USD 2,140 million in 2015 and is expected to grow at a CAGR of 2-5% during 2015 to 2020. Cervical cancer is generally characterized by the abnormal growth of cancerous cells in the tissues of the cervix, and it may manifest itself as a squamous-cell carcinoma or adenocarcinoma. According to the World Health Organization (WHO), cervical cancer accounts for the deaths of more than 270,000 women annually, primarily in the developing countries. With the increasing use of cervical cancer diagnostic tests such as pap smear tests, HPV testing and colposcopy for early detection, the market is highly competitive, with high growth rate. The advent of technologically advanced computer-guided screening tests for cervical caner, in order to reduce the rate of false-negative results, and improved accuracy are expected to contribute to the growth of the cervical cancer diagnostic tests market during the forecast period, from 2014 to 2020. Drivers:
Restraints:
Key Topics Covered: 1 Introduction 2 Executive summary 3. Market Overview 4. Porter's five force analysis 5. Market segmentation 6. Competitive Landscape 7. Company Profiles 8. Appendix Companies Mentioned:
For more information visit http://www.researchandmarkets.com/research/kzxsbb/global_cervical View source version on businesswire.com: http://www.businesswire.com/news/home/20160725005966/en/ |
